VOTUBIA

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom

Active ingredients

The drug VOTUBIA contains one active pharmaceutical ingredient (API):

1 Everolimus UNII 9HW64Q8G6G - EVEROLIMUS

Everolimus is a selective mTOR (mammalian target of rapamycin) inhibitor. mTOR is a key serine-threonine kinase, the activity of which is known to be upregulated in a number of human cancers. Read about Everolimus

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VOTUBIA Dispersible tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01EG02	Everolimus	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L01EG02
L04AH02	Everolimus	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AH Mammalian target of rapamycin (mTOR) kinase inhibitors
Discover more medicines within L04AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1539468, 1539479, 1539480, 1539503, 1539514, 1539525, 1539536, 1633890, 1639548, 1639559, 1639560, 1639571, 1639582, 1639593, 1639605, 1737727, 1774133
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 111710006, 111710010, 111710012, 111710014, 11710002, 11710004
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 068276, 138514, 399306, 467959, 549685
Country: FR	Base de données publique des médicaments	Identifier(s): 60223417, 61063232, 62601043, 64945242, 66520037, 69793977
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 197111, 197163, 216787, 341649, 341652, 341655
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8314
Country: IT	Agenzia del Farmaco	Identifier(s): 041397011, 041397023, 041397035, 041397047, 041397050, 041397062, 041397074, 041397086, 041397098, 041397100, 041397112, 041397124, 041397136, 041397148, 041397151, 041397163
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1062009, 1062010, 1062011, 1062012, 1062013, 1062014, 1062015, 1071835, 1072760, 1072778, 1072779, 1072780, 1072781, 1072782, 1072783, 1085818
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 100471, 113441, 139653, 92568, 92576
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100253844, 100253867, 100253873, 100387645, 100387651, 100387668, 100417228
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64600002, W64601001, W64602001, W64602002, W64603001, W64604001, W64605001